Technology DAYMONTHYEAR Demand for healthcare rising in growing economies People living longer Innovation in personalized medicine Prevalence of chronic conditions People taking a more active ID: 930963
Download Presentation The PPT/PDF document "Life-Changing Healthcare" is the property of its rightful owner. Permission is granted to download and print the materials on this web site for personal, non-commercial use only, and to display it on your personal computer provided you do not modify the materials and that you retain all copyright notices contained in the materials. By downloading content from our website, you accept the terms of this agreement.
Slide1
Life-Changing
HealthcareTechnology
DAY/MONTH/YEAR
Slide2Demand for healthcare rising
in growing economies
People living longer
Innovation in personalized medicine
Prevalence of chronic conditions
People taking a more active role in healthcare decisions to live their fullest lives
2
TACKLING CHALLENGING health needs around the world
58%OF SALES IN DEVELOPED MARKETS
42%OF SALES IN EMERGINGMARKETS
Proprietary and confidential — do not distribute
65
%
OF SALES OUTSIDE THE U.S.
Slide33
Transforming care
By giving people –
and their doctors –
timely information to better manage health
Diagnostics
Instrument systems and tests for hospitals, reference labs, clinics and blood banks
Lab-based tests for health screening,
disease diagnosis and monitoring
Gene-based diagnostics for managing infectious diseases and serious illnesses
Patient-side, rapid diagnostics for
lab-quality results in minutes
Sophisticated information solutions that create “smarter” labs for better care
Slide4Cardiometabolic
Afinion
™
2 Analyzer
Cholestech LDX™NycoCard™ READER IIHbA1c (diabetes)CRP (antibiotics)900+ MinuteClinic™ (CVS Health) locations have adopted Cholestech LDX™ and Afinion
™ systems
HbA1c (diabetes)
Lipids (cholesterol)ACR (renal disease)CRP (antibiotics)
Total CholesterolHDL CholesterolTriglyceridesGlucose
Chronic Care Management in Multiple Settings4
Slide5Afinion™ 2
SUBHEADS CALIBRI 18PT BOLD, ABBOTT BLUE
Slide6Afinion 2 System
The Afinion 2 Analyzer is the result of years of continuous product innovation and refinement, and delivers actionable point-of-care test results in just minutes.With its compact size and panel of tests, the Afinion 2 system is ideal for point-of-care testing in physician offices, clinics, community health centers, retirement homes, emergency rooms and hospital out patient clinics. From just a finger stick sized sample, lab accurate results for CRP, HbA1c, ACR and Lipid Panel are made available during the consultation.
6
Slide7The Afinion 2 SystemThe Afinion 2 Analyzer is a compact, rapid, multi-assay analyzer that provides valuable near patient testing at the point-of-care.
Available assaysAfinion HbA1cAfinion ACRAfinion Lipid PanelAfinion CRP
7
Slide8The Afinion 2 System
Easy to use
Delivering highly accurate results in minutes
Multi assay platform
HbA1c, ACR, Lipid and CRP
Finger stick sized sampleConnectivity, bi-directionalPatient and QC ID and results stored in memory QC and operator lockout Extensive and comprehensive failsafe systems prevent the possibility of erroneous results No operator calibration required No maintenance required8
Slide9The Afinion Assays
9
HbA1c
CRP
Lipid Panel
ACR
Afinion HbA1cis an in vitro diagnostic test for quantitative determination of glycated hemoglobin (hemoglobin A1c, HbA1c) in human whole blood. The measure of HbA1c is recommended as a marker of long-term metabolic control in persons with diabetes mellitus. This test can be used as an aid in the diagnosis of diabetes and as an aid in identifying patients who may be at risk for developing diabetes
.*
Afinion CRP is an in vitro diagnostic test for the quantitative determination of C-reactive protein (CRP) in human whole blood and in human serum and plasma. The measurement of CRP provides information for the detection and evaluation of infection, tissue injury, inflammatory disorders and associated diseases.
Afinion™ ACR is an in vitro diagnostic test for quantitative determination of albumin, creatinine and albumin/creatinine ratio (ACR) in human urine. The measurement of urine albumin, creatinine and ACR aids in the early diagnosis of nephropathy.
The Afinion™ Lipid Panel is an in vitro diagnostic test for quantitative determination of total cholesterol (Chol), high-density lipoprotein (HDL) cholesterol and triglycerides (Trig) in whole blood, serum and plasma. Values for low-density lipoprotein (LDL) cholesterol, non-HDL cholesterol and Chol/HDL ratio are calculated by the Afinion Analyzer. Cholesterol measurements are used in the diagnosis and treatment of disorders involving excess or low cholesterol in the blood and lipid and lipoprotein metabolism disorders.
*Afinion HbA1c
Dx
in the US.
Slide10The Afinion Assays
Each test kit contains 15 Test CartridgesThe test cartridges are single packed in aluminium foil bagsCompatible with both Alere Afinion
™ AS100 Analyzer and the Afinion™ 2 analyzer
10
Test kit box
Foil pouch containing one singe test cartridgeTest Cartridges
Slide11Cholestech LDX™
SUBHEADS CALIBRI 18PT BOLD, ABBOTT BLUE
Slide12The Cholestech LDX™ System
The Cholestech LDX™ System is a point-of-care testing system for measuring a lipid profile and glucose from a fingerstick or venous whole blood sample in just five minutes.
CLIA-Waived for ease of use
Results in 5 minutes
Fingerstick
sampling is less painful and less time-consumingSmall sample size (40µL)Highly accurate resultsCholesterol Reference MethodLaboratory Network (CRMLN) andLSP Certified12
Slide13The
Cholestech LDX™ System13
*
The Lipid Standardization Program (LSP) certifies
that laboratories are traceable to the CDC for total &
HDL cholesterol and triglycerides; the CholesterolReference Method Laboratory Network (CRMLN)certifies manufacturers of clinical diagnostic productsthat measure total and HDL cholesterol. Abbott andits distributors do not guarantee product coverage orreimbursement accuracy and appropriate usage of codes.
Slide14NycoCard™ READER II
SUBHEADS CALIBRI 18PT BOLD, ABBOTT BLUE
Slide15The NycoCard
™ Test System
15
The NycoCard test system is a platform that consists of the
NycoCard
READER II and the NycoCard assays:NycoCard CRPNycoCard HbA1c
Slide1616
A compact, light-weight,
benchtop
analyzer
20 x 17 x 7 cm, 0.54 kgFor quantitative measurement of the test results of all the NycoCard assaysNycoCard™ READER II
Slide17Minimal
maintenance required
Easily operated by 3 buttons
Portable
Battery operation possible
17NycoCard™ READER II key features
Slide18The NycoCard
™ assays18Two assays are available for the
NycoCard Test SystemNycoCard CRP
The measurement of CRP provides information for the detection and evaluation of infection, tissue injury, inflammatory disorders and associated diseases.
NycoCard
HbA1cFor monitoring long-term metabolic control in patients with diabetes mellitus.10005046-02 02/20
Slide19